로딩 중…
지수 로딩 중…
REGENXBIO Inc.
RGNX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$7.80-1.27%
2026-06-18
Price Chart
REGENXBIO Inc.-8.98%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $403M |
| Revenue | $88M |
| Net Income | $-290M |
| Total Assets | $342M |
| Net Assets | $161M |
| Value | |
| P/B | 2.50x |
| P/S | 4.59x |
| FCF Yield | -58.63% |
| Profitability | |
| ROE | -179.63% |
| ROA | -84.83% |
| Op. Margin | -292.28% |
| Revenue Growth | -92.82% |
| Earnings Growth | -1580.37% |
| Financial Health | |
| Debt Ratio | 198.70% |
| Total Debt | $71M |
| FCF | $-236M |
| Cash | $15M |
| Current Ratio | 2.62x |
| Performance | |
| 1Y Return | -8.98% |
| 1M Return | 37.81% |
| From 52W High | -51.82% |
| 1Y MDD | -64.64% |
| Trading | |
| Volume | 1,947,407 shares |
| Trading Value | $16M |
| Per Share | |
| EPS | $-3.75 |
| BPS | $1.99 |